France's pharmaceutical regulatory landscape's RAO market driver — the complexity of pharmaceutical regulatory affairs in France — navigating simultaneously the European Medicines Agency centralized procedure, ANSM national applications, France's innovative early access program (Accès Précoce), post-authorization variation management, and France-specific...